• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D cycle is cheaper and shorter. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments. Moreover, the number of competitors in the generic injectables market is lower as compared to oral generics, resulting in limited price erosion and significantly higher profit margins.

Global Generic Injectables Market Report

Owing to the advantages offered by generic injectables, governments in various countries are supporting their manufacture. Additionally, an increase in drug shortages, especially in the US, along with patent expiry of a number of blockbuster drugs, aging population and rising prevalence of chronic as well as lifestyle diseases represent some of the other factors driving the growth of the market. According to IMARC Group’s latest report titled, “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global generic injectables market reached a value of US$ 28.9 Billion in 2018. The report further anticipates the market to reach US$ 49.8 Billion by 2024, growing at a CAGR of 9.4% over the forecast period.

The report has segmented the market on the basis of therapeutic area as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular and others. Currently, the oncology segment accounts for the majority of the market share. Further, the report has segmented the market on the basis of distribution channels covering hospitals and retail pharmacy stores. Among these, hospitals account for the largest market share. On a regional-basis, the report covers North America, Europe, Asia, Latin America, and Middle East and Africa. North America represents the largest region, accounting for more than a half of the global market. The report has also analysed the competitive landscape of the market with some of the key players being Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter.

This report provides a deep insight into the global generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global generic injectables industry in any manner.

Key Questions Answered in This Report:

  • How has the generic injectables market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global generic injectables industry?
  • What are the price trends of generic injectables?
  • What are the various stages in the value chain of the generic injectables industry?
  • What are the key driving factors and challenges in the generic injectables industry?
  • What is the structure of the global generic injectables industry and who are the key players?
  • What is the degree of competition in the global generic injectables industry?
  • What are the profit margins in the generic injectables industry?
  • What are the key requirements for setting up a generic injectables manufacturing plant?
  • How are generic injectables manufactured?
  • What are the various unit operations involved in a generic injectables manufacturing plant?
  • What is the total size of land required for setting up a generic injectables manufacturing plant?
  • What are the machinery requirements for setting up a generic injectables manufacturing plant?
  • What are the raw material requirements for setting up a generic injectables manufacturing plant?
  • What are the packaging requirements for generic injectables?
  • What are the transportation requirements for generic injectables?
  • What are the utility requirements for setting up a generic injectables manufacturing plant?
  • What are the manpower requirements for setting up a generic injectables manufacturing plant?
  • What are the infrastructure costs for setting up a generic injectables manufacturing plant?
  • What are the capital costs for setting up a generic injectables manufacturing plant?
  • What are the operating costs for setting up a generic injectables manufacturing plant?
  • What will be the income and expenditures for a generic injectables manufacturing plant?
  • What is the time required to break-even?

1 Preface
2 Scope and Methodology

    2.1 Objectives of the Study
    2.2 Stakeholders
    2.3 Data Sources
        2.3.1 Primary Sources
        2.3.2 Secondary Sources
    2.4 Market Estimation
        2.4.1 Bottom-Up Approach
        2.4.2 Top-Down Approach
    2.5 Forecasting Methodology
3 Executive Summary
4 Introduction

    4.1 Overview    
    4.2 Key Industry Trends
5 Global Generic Drug Market
    5.1 Market Overview
    5.2 Market Performance
    5.3 Market Breakup by Region
    5.4 Market Forecast
    5.5 Major Players
6 Global Generic Drug Delivery Market
    6.1 Oral
    6.2 Injectables   
    6.3 Dermal/Topical
    6.4 Inhalers
7 Global Generic Injectables Market
    7.1 Market Overview
    7.2 Market Performance
    7.3 Market Breakup by Region
    7.4 Market Breakup by Therapeutic Area
    7.5 Market Breakup by Container
    7.6 Market Breakup by Distribution Channel
    7.7 Market Forecast
    7.8 SWOT Analysis
        7.8.1 Overview
        7.8.2 Strengths
        7.8.3 Weaknesses
        7.8.4 Opportunities
        7.8.5 Threats
    7.9 Value Chain Analysis
    7.10 Porter’s Five Forces Analysis
        7.10.1 Overview
        7.10.2 Bargaining Power of Buyers
        7.10.3 Bargaining Power of Suppliers
        7.10.4 Degree of Competition
        7.10.5 Threat of New Entrants
        7.10.6 Threat of Substitutes
     7.11 Key Market Drivers and Success Factors
8 Global Generic Injectables Market: Performance of Key Regions
    8.1 North America
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2 Europe
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3 Asia
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4 Latin America
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5 Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Forecast
9 Market by Therapeutic Area
    9.1 Oncology
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2 Anaesthesia
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3 Anti-infectives
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4 Parenteral Nutrition
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5 Cardiovascular
        9.5.1 Market Trends
        9.5.2 Market Forecast
10 Market by Container
     10.1 Vials
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2 Ampoules
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3 Premix
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4 Prefilled Syringes
        10.4.1 Market Trends
        10.4.2 Market Forecast
11 Market by Distribution Channel
     11.1 Hospitals
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2 Retail Pharmacy 
        11.2.1 Market Trends
        11.2.2 Market Forecast
12 Global Generic Injectable Market: Competitive Landscape
    12.1 Competitive Structure
    12.2 Market Breakup by Key Players    
13 Generic Injectable Manufacturing Process
    13.1 Product Overview
    13.2 Detailed Process Flow (Injectable)
    13.3 Various Types of Unit Operations Involved
    13.4 Mass Balance and Raw Material Requirements
14 Project Details, Requirements and Costs Involved
    14.1 Land Requirements and Expenditures
    14.2 Construction Requirements and Expenditures
    14.3 Plant Machinery
    14.4 Machinery Pictures
    14.5 Raw Material Requirements and Expenditures
    14.6 Packaging Requirements and Expenditures
    14.7 Transportation Requirements and Expenditures
    14.8 Utility Requirements and Expenditures
    14.9 Manpower Requirements and Expenditures
    14.10 Other Capital Investments
15 Loans and Financial Assistance
16 Project Economics

    16.1 Capital Cost of the Project
    16.2 Techno-Economic Parameters
    16.3 Product Pricing and Margins Across Various Levels of the Supply Chain
    16.4 Taxation and Depreciation
    16.5 Income Projections
    16.6 Expenditure Projections
    16.7 Financial Analysis
    16.8 Profit Analysis
17 Key Player Profiles
     17.1 Hospira (Pfizer)
         17.1.1 Company Overview
         17.1.2 Product Portfolio
         17.1.3 Financials
         17.1.4 SWOT Analysis
     17.2 Fresenius Kabi
         17.2.1 Company Overview
         17.2.2 Product Portfolio
         17.2.3 Financials
         17.2.4 SWOT Analysis
     17.3 Hikma
         17.3.1 Company Overview
         17.3.2 Product Portfolio
         17.3.3 Financials
         17.3.4 SWOT Analysis
     17.4 Sandoz (Novartis)
         17.4.1 Company Overview
         17.4.2 Product Portfolio
         17.4.3 Financials
         17.4.4 SWOT Analysis
     17.5 Sagent
         17.5.1 Company Overview
         17.5.2 Product Portfolio
         17.5.3 Financials
         17.5.4 SWOT Analysis
     17.6 Sanofi
         17.6.1 Company Overview
         17.6.2 Product Portfolio
         17.6.3 Financials
         17.6.4 SWOT Analysis
     17.7 Baxter
         17.7.1 Company Overview
         17.7.2 Product Portfolio
         17.7.3 Financials
         17.7.4 SWOT Analysis

List of Figures

Figure 1: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2011 - 2018
Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2018
Figure 3: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2019 - 2024
Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2011, 2018 & 2024
Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2011, 2018 & 2024
Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2011, 2018 & 2024
Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2011, 2018 & 2024
Figure 8: Global: Generic Injectables Market: Sales Value Trends (in Billion US$), 2011 - 2018
Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2018
Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2018
Figure 11: Global: Generic Injectables Market: Breakup by Container (in %), 2018
Figure 12: Global: Generic Injectables Market: Breakup by Distribution Channels (in %), 2018
Figure 13: Global: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2019 - 2024
Figure 14: Global: Generic Injectables Industry: SWOT Analysis
Figure 15: Global: Generic Injectables Industry: Value Chain Analysis
Figure 16: Global: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 17: North America: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
Figure 18: Europe: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
Figure 19: Asia: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
Figure 20: Latin America: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
Figure 21: Middle East and Africa: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
Figure 22: Global: Generic Injectable (Oncology) Market: Value Trends (in Million US$), 2011 & 2018
Figure 23: Global: Generic Injectable (Oncology) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 24: Global: Generic Injectable (Anaesthesia) Market: Value Trends (in Million US$), 2011 & 2018
Figure 25: Global: Generic Injectable (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 26: Global: Generic Injectable (Anti-infectives) Market: Value Trends (in Million US$), 2011 & 2018
Figure 27: Global: Generic Injectable (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 28: Global: Generic Injectable (Parenteral Nutrition) Market: Value Trends (in Million US$), 2011 & 2018
Figure 29: Global: Generic Injectable (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 30: Global: Generic Injectable (Cardiovascular) Market: Value Trends (in Million US$), 2011 & 2018
Figure 31: Global: Generic Injectable (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 32: Global: Generic Injectable (Vials) Market: Value Trends (in Million US$), 2011 & 2018
Figure 33: Global: Generic Injectable (Vials) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 34: Global: Generic Injectable (Ampoules) Market: Value Trends (in Million US$), 2011 & 2018
Figure 35: Global: Generic Injectable (Ampoules) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 36: Global: Generic Injectable (Premix) Market: Value Trends (in Million US$), 2011 & 2018
Figure 37: Global: Generic Injectable (Premix) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 38: Global: Generic Injectable (Prefilled Syringes) Market: Value Trends (in Million US$), 2011 & 2018
Figure 39: Global: Generic Injectable (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 40: Global: Generic Injectable Market: Sales through Hospitals (in Million US$), 2011 & 2018
Figure 41: Global: Generic Injectable Market Forecast: Sales through Hospitals (in Million US$), 2019-2024
Figure 42: Global: Generic Injectable Market: Sales through Retail Pharmacy (in Million US$), 2011 & 2018
Figure 43: Global: Generic Injectable Market Forecast: Sales through Retail Pharmacy (in Million US$), 2019-2024
Figure 44: Generic Injectable Manufacturing Process: Conversion Rate of Feedstocks
Figure 45: Generic Injectable Manufacturing: Detailed Process Flow
Figure 46: Generic Injectable Manufacturing: Production Cost Breakup (in %)
Figure 47: Generic Injectable Industry: Profit Margins at Various Levels of the Supply Chain
Figure 48: Generic Injectable Manufacturing Plant: Proposed Plant Layout
Figure 49: Generic Injectable Manufacturing Plant: Breakup of Capital Costs (in %)

List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2018 and 2024
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2019 - 2024
Table 3: Global: Generic Drug Market: Revenues of Key Players (in Billion US$), 2018
Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2018 and 2024
Table 5: Global: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2019 - 2024
Table 6: Global: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2019 - 2024
Table 7: Global: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2019 - 2024
Table 8: Global: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2019 - 2024
Table 9: Generic Injectable Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 10: Generic Injectable Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 11: Generic Injectable Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 12: Generic Injectable Manufacturing Plant: Raw Material Requirements (Kg/Day) and Expenditures (US$/Kg)
Table 13: Generic Injectable Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 14: Generic Injectable Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 15: Details of Financial Assistance Offered by Financial Institutions
Table 16: Generic Injectable Manufacturing Plant: Capital Costs (in US$)
Table 17: Generic Injectable Manufacturing Plant: Techno-Economic Parameters (in US$)
Table 18: Generic Injectable Manufacturing Plant: Taxation and Depreciation (in US$)
Table 19: Generic Injectable Manufacturing Plant: Income Projections (in US$)
Table 20: Generic Injectable Manufacturing Plant: Expenditure Projections (in US$)
Table 21: Generic Injectable Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 22: Generic Injectable Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 23: Generic Injectable Manufacturing Plant: Profit and Loss Account (in US$)

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links